Atara Biotherapeutics Stock (NASDAQ: ATRA) stock price, news, charts, stock research, profile.
Open | $7.87 |
Close | - |
Volume / Avg. | 99.30K / 133.29K |
Day Range | $7.39 - $7.95 |
52 Wk Range | 4.97 - 49.00 |
Market Cap | $42.90M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 7.33% |
Days to Cover | 6.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.
Other companies in Atara Biotherapeutics’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR), OncoCyte (NASDAQ:OCX) and CARISMA Therapeutics (NASDAQ:CARM).
Atara Biotherapeutics has a consensus price target of $13.77.
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $7.56 last updated September 23, 2024 at 1:48 PM EDT.
There are no upcoming dividends for Atara Biotherapeutics.
Atara Biotherapeutics’s Q3 earnings are confirmed for Wednesday, October 30, 2024.
There is no upcoming split for Atara Biotherapeutics.
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.